The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis

Tim Rosenow, L. Clara Mok, Lidija Turkovic, Luke J. Berry, Peter D. Sly, Sarath Ranganathan, Harm A.W.M. Tiddens, Stephen M. Stick

Source: Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018
Journal Issue: July
Disease area: Paediatric lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tim Rosenow, L. Clara Mok, Lidija Turkovic, Luke J. Berry, Peter D. Sly, Sarath Ranganathan, Harm A.W.M. Tiddens, Stephen M. Stick. The cumulative effect of inflammation and infection on structural lung disease in early cystic fibrosis. Eur Respir J, 54 (1) 1801771; 10.1183/13993003.01771-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017



Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014


Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020



Longitudinal changes in lung function and the association with pulmonary structure and infection in infants with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008

The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006

Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020




Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002

Inflammation and infection in infants with cystic fibrosis is associated with changes in lung function in the first year of life
Source: Annual Congress 2008 - Respiratory physiology in health and disease
Year: 2008

Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019


Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Source: Eur Respir J, 51 (2) 1701704; 10.1183/13993003.01704-2017
Year: 2018



The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018



New insights into the pathophysiology of lung disease in cystic fibrosis patients
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1
Year: 2006

How much genotype influences cystic fibrosis associated liver disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 717s
Year: 2006

Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014


Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
Source: Eur Respir J, 52 (3) 1702529; 10.1183/13993003.02529-2017
Year: 2018



Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009


Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002

Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018